(September 3, 2024, 12:04 PM EDT) -- CLEVELAND — Third-party payers (TPP) in the opioid multidistrict litigation moved on Aug. 30 for preliminary approval of a $300 million settlement reached with three drug manufacturers to end claims that the opioid industry’s practices caused them to pay more for prescription opioids instead of safer, less addictive alternatives and for the cost of funding opioid addiction-related treatments....